---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-000871"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2026-06-17T20:32:20+00:00"
generated_at: "2026-06-17T20:35:21.785190+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lunai Bioworks lands first defense contract, sues naked short sellers over 81.6% FTD shares

## Summary
- Secured first revenue-generating multi-year defense collaboration via BioSymetrics for chemical threat assessment.
- Formed Pathfinder Consortium with Harvard, Brigham & Women's, Purdue, Utah, Colorado for biodefense.
- Partnered with BrainStorm Therapeutics; awarded $1.85M NIH STTR grant for alcohol use disorder.
- Filed May 2026 lawsuit against unidentified parties; 29.6M fails-to-deliver (81.6% of shares); court granted expedited discovery.
- Achieved compliance with Nasdaq listing requirements.

## SEC filing metadata
- accession: 0001731122-26-000871
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2026-06-17T20:32:20+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/0001731122-26-000871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/e7731_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-000871
- JSON: https://secwatch.observer/filing/0001731122-26-000871.json
- Plain text: https://secwatch.observer/filing/0001731122-26-000871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.